NAD+ Biosynthesis Ameliorates a Zebrafish Model of Muscular Dystrophy

PLoS Biology

Volumn 10, Issue 10, 2012, Pages

  Goody, Michelle F ^a   Kelly, Meghan W ^a   Reynolds, Christine J ^b   Khalil, Andre ^a,c   Crawford, Bryan D ^d   Henry, Clarissa A ^a,c  

^a UNIVERSITY OF MAINE   (United States)

^b Colby College   (United States)

^c JACKSON LABORATORY   (United States)

^d UNIVERSITY OF NEW BRUNSWICK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; ALPHA7 INTEGRIN; DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; INTEGRIN RECEPTOR; LAMININ; LAMININ RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE RIBOSIDE KINASE 2B; PAXILLIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL ANCHORAGE; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EXTRACELLULAR MATRIX; MUSCLE ATROPHY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE METABOLISM; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SWIMMING; UPREGULATION; WILD TYPE; ZEBRA FISH;

ANIMALS; ANTIGENS, CD; CELL ADHESION; DISEASE MODELS, ANIMAL; DYSTROGLYCANS; DYSTROPHIN; EXTRACELLULAR MATRIX; INTEGRIN ALPHA CHAINS; INTEGRIN ALPHA6; LAMININ; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; NAD; PAXILLIN; ZEBRAFISH; ZEBRAFISH PROTEINS;

DANIO RERIO;

EID: 84868108276     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001409     Document Type: Article

References (72)

1. Morgan JE, Zammit PS, (2010) Direct effects of the pathogenic mutation on satellite cell function in muscular dystrophy. Exp Cell Res 316: 3100-3108.
2. Moll J, Barzaghi P, Lin S, Bezakova G, Lochmüller H, et al. (2001) An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 413: 302-307.
3. Bentzinger CF, Barzaghi P, Lin S, Ruegg MA, (2005) Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-α2-deficient mice. FASEB J 19: 934-942.
4. Jacoby AS, Busch-Nentwich E, Bryson-Richardson RJ, Hall TE, Berger J, et al. (2009) The zebrafish dystrophic mutant softy maintains muscle fibre viability despite basement membrane rupture and muscle detachment. Development 136: 3367-3376.
5. Ibraghimov-Beskrovnaya OO, Ervasti JMJ, Leveille CJC, Slaughter CAC, Sernett SWS, et al. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696-702.
6. Gee SHS, Montanaro FF, Lindenbaum MHM, Carbonetto SS, (1994) Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77: 675-686.
7. Yamada HH, Shimizu TT, Tanaka TT, Campbell KPK, Matsumura KK, (1994) Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett 352: 49-53.
8. Ervasti JM, Campbell KP, (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122: 809-823.
9. Frost AR, Böhm SV, Sewduth RN, Josifova D, Ogilvie CM, et al. (2010) Heterozygous deletion of a 2-Mb region including the dystroglycan gene in a patient with mild myopathy, facial hypotonia, oral-motor dyspraxia and white matter abnormalities. Eur J Hum Genet 18: 852-855.
10. Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, Kanagawa M, Beltrán-Valero de Bernabé D, et al. (2011) A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med 364: 939-946.
11. Inamori K-I, Yoshida-Moriguchi T, Hara Y, Anderson ME, Yu L, et al. (2012) Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 335: 93-96.
12. Godfrey C, Foley AR, Clement E, Muntoni F, (2011) Dystroglycanopathies: coming into focus. Curr Opin Genet Dev 21: 278-285.
13. Mercuri E, Messina S, Bruno C, Mora M, Pegoraro E, et al. (2009) Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology 72: 1802-1809.
14. Jimenez-Mallebrera C, Torelli S, Feng L, Kim J, Godfrey C, et al. (2009) A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity. Brain Pathol 19: 596-611.
15. Steffen LS, Guyon JR, Vogel ED, Beltre R, Pusack TJ, et al. (2007) Zebrafish orthologs of human muscular dystrophy genes. BMC Genomics 8: 79.
16. Moore CJ, Goh HT, Hewitt JE, (2008) Genes required for functional glycosylation of dystroglycan are conserved in zebrafish. Genomics 92: 159-167.
17. Lin Y-Y, White RJ, Torelli S, Cirak S, Muntoni F, et al. (2011) Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies. Hum Mol Genet 20: 1763-1775.
18. Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, et al. (2009) Inaugural article: basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of α-dystroglycan. Proc Natl Acad Sci U S A 106: 12573-12579.
19. Mayer U, Saher G, Fässler R, Bornemann A, Echtermeyer F, et al. (1997) Absence of integrin α7 causes a novel form of muscular dystrophy. Nat Genet 17: 318-323.
20. Van Der Flier A, Gaspar A, (1997) Spatial and temporal expression of the β1D integrin during mouse development. Dev Dyn 102: 472-486.
21. Banks GB, Combs AC, Chamberlain JR, Chamberlain JS, (2008) Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin. Hum Mol Genet 17: 3975-3986.
22. Burkin DJ, Wallace GQ, Milner DJ, Chaney EJ, Mulligan JA, et al. (2005) Transgenic expression of α7β1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice. Am J Pathol 166: 253-263.
23. Doe JA, Wuebbles RD, Allred ET, Rooney JE, Elorza M, et al. (2011) Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dyW mouse model of merosin-deficient congenital muscular dystrophy type 1A. J Cell Sci 124: 2287-2297.
24. Rooney JE, Welser JV, Dechert MA, Flintoff-Dye NL, Kaufman SJ, et al. (2006) Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. J Cell Sci 119: 2185-2195.
25. Guo C, (2006) Absence of α7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. Hum Mol Genet 15: 989-998.
26. Snow CJ, Henry CA, (2009) Dynamic formation of microenvironments at the myotendinous junction correlates with muscle fiber morphogenesis in zebrafish. Gene Expr Patterns 9: 37-42.
27. Goody MF, Kelly MW, Lessard KN, Khalil A, Henry CA, (2010) Nrk2b-mediated NAD+ production regulates cell adhesion and is required for muscle morphogenesis in vivo: Nrk2b and NAD+ in muscle morphogenesis. Dev Biol 344: 809-826.
28. Bieganowski P, Brenner C, (2004) Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell 117: 495-502.
29. Tempel W, Rabeh WM, Bogan KL, Belenky P, Wojcik M, et al. (2007) Nicotinamide riboside kinase structures reveal new pathways to NAD. PloS Biol 5: e263 doi:10.1371/journal.pbio.0050263.sg001.
30. Parsons M, Campos I, Hirst E, Stemple D, (2002) Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos. Development 129: 3505-3512.
31. Li J, Rao H, Burkin D, Kaufman SJ, Wu C, (2003) The muscle integrin binding protein (MIBP) interacts with alpha7beta1 integrin and regulates cell adhesion and laminin matrix deposition. Dev Biol 261: 209-219.
32. Williamson R, Henry M, Daniels K, (1997) Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Human Molecular Genetics 6: 831-841.
33. Sztal T, Berger S, Currie PD, Hall TE, (2011) Characterization of the laminin gene family and evolution in zebrafish. Dev Dyn 240: 422-431.
34. Arnedo A, Decoster N, Roux S, (2000) A wavelet-based method for multifractal image analysis. I. Methodology and test applications on isotropic and anisotropic random rough surfaces. Eur Phys J B 15: 567-600.
35. Khalil A, Joncas G, Nekka F, Kestener P, Arneodo A, (2006) Morphological analysis of H iFeatures. II. Wavelet-based multifractal formalism. Astrophys J Suppl S 165: 512-550.
36. Snow CJ, Goody M, Kelly MW, Oster EC, Jones R, et al. (2008) Time-lapse analysis and mathematical characterization elucidate novel mechanisms underlying muscle morphogenesis. PLoS Genet 4: e1000219 doi:10.1371/journal.pgen.1000219.
37. Hasegawa T, Matsumura K, Hashimoto T, Ikehira H, Fukuda H, et al. (1992) Intramuscular degeneration process in Duchenne muscular dystrophy-investigation by longitudinal MR imaging of the skeletal muscles. Rinsho Shinkeigaku 32: 333-335.
38. Nagao H, Morimoto T, Sano N, (1991) Magnetic resonance imaging of skeletal muscle in patients with Duchenne muscular dystrophy-serial axial and sagittal section studies. Brain 23: 39-43.
39. Hall TE, Bryson-Richardson RJ, Berger S, Jacoby AS, Cole NJ, et al. (2007) The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy. Proc Natl Acad Sci U S A 104: 7092-7097.
40. Granato M, Van Eeden F, Schach U, Trowe T, (1996) Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development 123: 399-413.
41. Hayashi YK, Chou F-L, Engvall E, Ogawa M, Matsuda C, et al. (1998) Mutations in the integrin α7 gene cause congenital myopathy. Nat Genet 19: 94-97.
42. Postel R, Vakeel P, Topczewski J, Knöll R, Bakkers J, (2008) Zebrafish integrin-linked kinase is required in skeletal muscles for strengthening the integrin-ECM adhesion complex. Dev Biol 318: 92-101.
43. Parsons MJ, Pollard SM, Saúde L, Feldman B, Coutinho P, et al. (2002) Zebrafish mutants identify an essential role for laminins in notochord formation. Development 129: 3137-3146.
44. Humphries JD, Byron A, Humphries MJ, (2006) Integrin ligands at a glance. J Cell Sci 119: 3901-3903.
45. Terpe HJ, Stark H, Ruiz P, Imhof BA, (1994) Alpha 6 integrin distribution in human embryonic and adult tissues. Histochem Cell Biol 101: 41-49.
46. Bajanca F, Luz M, Raymond K, Martins GG, Sonnenberg A, et al. (2006) Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. Development 133: 1635-1644.
47. Wilschut KJ, Haagsman HP, Roelen BAJ, (2010) Extracellular matrix components direct porcine muscle stem cell behavior. Exp Cell Res 316: 341-352.
48. Wilschut KJ, van Tol HTA, Arkesteijn GJA, Haagsman HP, Roelen BAJ, (2011) Alpha 6 integrin is important for myogenic stem cell differentiation. Stem Cell Res 7: 112-123.
49. Castaldo C, Di Meglio F, Nurzynska D, Romano G, Maiello C, et al. (2008) CD117-positive cells in adult human heart are localized in the subepicardium, and their activation is associated with laminin-1 and alpha6 integrin expression. Stem Cells 26: 1723-1731.
50. Dolez M, Nicolas J-F, Hirsinger E, (2011) Laminins, via heparan sulfate proteoglycans, participate in zebrafish myotome morphogenesis by modulating the pattern of Bmp responsiveness. Development 138: 97-106.
51. Eisen JS, Smith JC, (2008) Controlling morpholino experiments: don't stop making antisense. Development 135: 1735-1743.
52. Robu ME, Larson JD, Nasevicius A, Beiraghi S, Brenner C, et al. (2007) p53 activation by knockdown technologies. PLoS Genet 3: e78 doi:10.1371/journal.pgen.0030078.
53. Tzu J, Marinkovich MP, (2008) Bridging structure with function: structural, regulatory, and developmental role of laminins. Int J Biochem Cell Biol 40: 199-214.
54. Gawlik K, Miyagoe-Suzuki Y, Ekblom P, Takeda S, Durbeej M, (2004) Laminin α1 chain reduces muscular dystrophy in laminin α2 chain deficient mice. Hum Mol Genet 13: 1775-1784.
55. Rooney JE, Knapp JR, Hodges BL, Wuebbles RD, Burkin DJ, (2012) Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy. Am J Pathol 180: 1593-1602.
56. Rooney JE, Gurpur PB, Burkin DJ, (2009) Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 106: 7991-7996.
57. Serena E, Zatti S, Reghelin E, Pasut A, Cimetta E, et al. (2010) Soft substrates drive optimal differentiation of human healthy and dystrophic myotubes. Integr Biol (Camb) 2: 193-201.
58. Georges-Labouesse E, Messaddeq N, Yehia G, (1996) Absence of integrin α6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet 13: 370-373.
59. Deakin NO, Turner CE, (2008) Paxillin comes of age. J Cell Sci 121: 2435-2444.
60. Crawford BD, Henry CA, Clason TA, Becker AL, Hille MB, (2003) Activity and distribution of paxillin, focal adhesion kinase, and cadherin indicate cooperative roles during zebrafish morphogenesis. Mol Biol Cell 14: 3065-3081.
61. Spiczka KS, Yeaman C, (2008) Ral-regulated interaction between Sec5 and paxillin targets Exocyst to focal complexes during cell migration. J Cell Sci 121: 2880-2891.
62. Hagel M, George EL, Kim A, Tamimi R, Opitz SL, et al. (2002) The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol Cell Biol 22: 901-915.
63. Mazaki Y, (1998) Paxillin isoforms in mouse. Lack of the gamma isoform and developmentally specific beta isoform expression. J Biol Chem 273: 22435-22441.
64. Kawahara G, Karpf JA, Myers JA, Alexander MS, Guyon JR, et al. (2011) Drug screening in a zebrafish model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 108: 5331-5336.
65. Eliasson M, Sampei K, Mandir A, (1997) Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature 3: 1089-1095.
66. Ieraci A, Herrera DG, (2006) Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain. PLoS Med 3: e101 doi:10.1371/journal.pmed.0030101.
67. Altschul R, Hoffer A, Stephen JD, (1955) Influence of nicotinic acid on serum cholesterol in man. Arch Biochem Biophys 54: 558-559.
68. Hausenloy DJ, Yellon DM, (2009) Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels. Curr Opin Cardiol 24: 473-482.
69. Shehadah A, Chen J, Zacharek A, Cui Y, Ion M, et al. (2010) Niaspan treatment induces neuroprotection after stroke. Neurobiol Dis 40: 277-283.
70. Cho K-H, Kim H-J, Kamanna VS, Vaziri ND, (2010) Niacin improves renal lipid metabolism and slows progression in chronic kidney disease. Biochim Biophys Acta 1800: 6-15.
71. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF, (2005) Stages of embryonic development of the zebrafish. Dev Dyn 203: 253-310.
72. Wiellette E, Grinblat Y, Austen M, Hirsinger E, (2004) Combined haploid and insertional mutation screen in the zebrafish. Genesis 40: 231-240.